HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, K. Articles by Weng, N.-p. Search for Related Content PubMed PubMed Citation Articles by Liu, K. Articles by Weng, N.-p.

Cutting Edge: Telomerase Activation in Human T Lymphocytes Does Not Require Increase in Telomerase Reverse Transcriptase (hTERT) Protein But Is Associated with hTERT Phosphorylation and Nuclear Translocation

Kebin Liu^*, Richard J. Hodes and Nan-ping Weng^1,*

^* Laboratory of Immunology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; and Experimental Immunology Branch, National Cancer Institute, and National Institute on Aging, National Institutes of Health, Bethesda, MD 20892

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Capacity for cellular replication is critically important for lymphocyte function and can be regulated by telomerase-dependent maintenance of telomere length. In contrast to most normal human somatic cells that do not express telomerase due to the failure to transcribe telomerase reverse transcriptase (hTERT), lymphocytes express telomerase in a highly regulated fashion yet constitutively transcribe hTERT during development and activation. Here, we report that hTERT protein is present in both thymocytes and blood T cells at equivalent levels despite their substantial differences in telomerase activity, and that induction of telomerase activity in resting CD4⁺ T cells is not dependent on net hTERT protein increase. Moreover, hTERT is phosphorylated and translocated from cytoplasm to nucleus during CD4⁺ T cell activation. Thus, human T lymphocytes regulate telomerase function through novel events independent of hTERT protein levels, and hTERT phosphorylation and nuclear translocation may play a role in regulation of telomerase function in lymphocytes.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Telomerase, a complex ribonucleoprotein enzyme, functions to synthesize telomere repeats, compensating for the telomere loss that accompanies cell division and chromosomal replication, and thus prolonging telomere length-restricted replicative life span of cells (1, 2, 3). Telomerase activity is constitutively expressed in germline cells and in the majority of malignant tumor cells and is repressed in most human normal somatic cells (4, 5). Strikingly, however, telomerase activity is expressed in a highly regulated manner in certain somatic cell populations such as lymphocytes and hemopoietic stem cells (6, 7, 8, 9, 10). This selective expression of telomerase provides a molecular basis for the mortality and immortality of cells and is in addition an important consideration for development of telomerase-based therapeutics for extending the replicative life span of normal cells and for limiting the growth of malignant tumor cells.

Studies of telomerase regulation in normal somatic cells have focused on expression of the two essential components of telomerase, telomerase RNA template (hTER)² (11) and telomerase reverse transcriptase (hTERT) (12, 13). hTER appears to be ubiquitously present in all cells regardless of telomerase enzymatic activity (11). In contrast, it has been reported that hTERT mRNA is detected only in telomerase-positive germline and malignant tumor cells but not in telomerase-negative fibroblasts or other somatic cells (3). These findings have led to the conclusion that telomerase activity is determined at the level of hTERT transcription in normal somatic cells. Recent studies have suggested that telomerase activity can also be regulated by alternative splicing of hTERT transcripts, at times with resulting loss of enzymatic activity, as observed during fetal kidney development (14, 15) and in some tumor cells (15, 16).

It has been well documented that telomerase activity is expressed in a highly regulated fashion during human lymphocyte development, differentiation, and activation (7, 17, 18, 19, 20). Activation of peripheral blood T lymphocytes can increase both the levels of hTERT transcripts and telomerase activity. However, we recently reported that hTERT transcripts are present at similar levels in human thymocytes and tonsil and peripheral blood T and B cells independent of the status of telomerase activity in these cells (21). These results indicate that transcriptional regulation of hTERT alone does not determine telomerase activity in human lymphocytes. We report here that hTERT protein, like its transcript, is present in all subsets of lymphocytes isolated from thymus and peripheral blood regardless of the status of telomerase activity. Furthermore, activation of telomerase in peripheral blood CD4⁺ T lymphocytes after stimulation does not require an increase of hTERT protein. We further demonstrate that phosphorylation and nuclear translocation of hTERT are induced by activation of human CD4⁺ T cells. These findings suggest that human lymphocytes use novel mechanisms in regulating telomerase activity.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
T cell subsets isolation and in vitro stimulation conditions

Peripheral blood samples were obtained with informed consent from normal donors of the National Institutes of Health Blood Bank, and thymi were obtained during elective pediatric cardiac surgery at Fairfax County Hospital (Fairfax, VA) following National Institutes of Health guidelines. The procedures for isolation and stimulation of thymocytes, peripheral blood CD4⁺ and CD8⁺ T cells, and naive (CD45RA⁺) and memory (CD45RO⁺) CD4⁺ T cells were previously described (18).

Cell proliferation and flow cytometry

The measurement of lymphocyte proliferation after in vitro stimulation was previously described (22). The purity of isolated CD4⁺ T cells and naive and memory CD4⁺ T cells was analyzed by FACScan (Becton Dickinson, Mountain View, CA) as described (23).

Western blot and immunoprecipitation analysis

Total cell lysate was prepared by standard protocol. Cytosol and nuclear extract were prepared as previously described (24). Cellular proteins from 1 x 10⁷ cells were separated by 6% SDS-PAGE, transferred to Immobilon-P membranes (Millipore, Bedford, MA), probed with anti-hTERT Ab K-370 (Calbiochem, La Jolla, CA) (25) at 1:2000 dilution, and detected using the ECL Plus Western detecting kit (Amersham Pharmacia Biotech, Piscataway, NJ). The membranes were stripped and probed again with anti-ZAP70 Ab (a gift from Dr. Ronald Wange, National Institute on Aging/National Institutes of Health). As a negative control, human fibroblasts (26) were used, and anti--tubulin Ab (Sigma-Aldrich, St. Louis, MO) was used at a 1:2000 dilution as a loading control. Immunoprecipitation of hTERT was conducted with anti-hTERT K-370. Immunoprecipitates were separated by 6% SDS-PAGE, transferred to Immobilon-P membranes (Millipore), and probed with either K-370 or H-231 (Santa Cruz Biotechnology, Santa Cruz, CA) anti-hTERT Ab. The specificity of Ab K-370 was determined by preincubating Ab with the immunizing peptide (PEPT-1, FQKNRLFFYRKSVWC) or with a nonspecific peptide of the same length and amino acid composition (PEPT-2, WFVQNLRYFKFKRSC), and then assaying remaining Ab activity by immunoblotting.

Telomerase activity assay

Telomerase activity was measured by a modified telomeric repeats amplification protocol (TRAP) assay as described (21, 27).

Phosphorylation analysis of hTERT by radiolabeling

Based on a previously described protocol for determining phosphorylation by radiolabeling (28), we cultured freshly isolated CD4⁺ T cells (7.5 x 10⁷) with either IL-2 (100 U/ml; Roche Molecular Biochemicals, Burlington, NC) or anti-CD3/CD28 Abs for 1.5 days and pulsed with 5 mCi [³²P]orthophosphate (NEN Life Science, Boston, MA) in a phosphate-free RPMI 1640 medium for 4 h. Cell lysates were prepared, immunoprecipitated with anti-hTERT Abs and agarose-immobilized protein A, and separated by 12% SDS-PAGE. Autoradiography and Western blot were then conducted.

Subcellular localization of hTERT by confocol microscopy

Freshly isolated and stimulated CD4⁺ T cells were fixed in 3.7% formaldehyde in PBS at 4°C overnight (or up to 1 wk), then permeablized with 0.1% Triton X-100 in PBS for 3 min. After three washes with PBS, cells were blocked with PBS containing 1% BSA for 30 min at room temperature followed by incubation with a 1:1000 dilution of anti-hTERT Ab K-370 for 1 h at room temperature in PBS containing 1% BSA. The stained cells were washed three times with PBS and incubated with a 1:400 dilution of Alexa Fluor 568 goat anti-rabbit IgG conjugate (Molecular Probes, Eugene, OR) for 1 h at room temperature. 4',6'-diamidino-2-phenylindole (2.5 µg/ml) was then added to the cell-Ab suspension and incubated at room temperature for another 10 min. The cells were washed three times with PBS and examined by confocal microscopy (Zeiss, Oberkochen, Germany).

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
hTERT protein expression in human T lymphocyte lineage

In an effort to assess the levels at which telomerase activity is regulated in human lymphocytes, we measured hTERT protein in thymocytes and peripheral blood T lymphocytes by Western blot. First, we characterized the specificity of an anti-hTERT Ab, K-370, which was generated against a synthetic peptide corresponding to amino acids 568–581 of hTERT (25). When lysates prepared from resting CD4 T cells were analyzed by electrophoresis and immunoblotting, the anti-hTERT Ab K-370 recognized a polypeptide with a molecular mass of 130 kDa, as expected for the hTERT protein. Moreover, immunoblotting with K-370 was blocked by preincubation of K-370 with the antigenic hTERT peptide, but not by a control peptide with the same amino acid composition (Fig. 1A). In addition, a second anti-hTERT Ab H231, which was raised against a recombinant protein corresponding to amino acids 900-1130 of hTERT, recognized the polypeptide immunoprecipitated with anti-hTERT K-370 (Fig. 2B). These results confirmed the hTERT specificity of Ab K-370, which was used in subsequent experiments.

View larger version (34K): [in this window] [in a new window]   FIGURE 1. Identification of hTERT by immunoprecipitation and immunoblogtting. A, Western blot analysis of total cell lysates from CD4+ T cells using K-370 Abs alone (control) or in the presence of the antigenic peptide (PEPT-1) or a nonspecific peptide (PEPT-2). B, Immunoprecipitation of lysates from CD4+ T cells with anti-hTERT Ab K-370 specific for hTERT peptide 568–581 and immunoblotting with anti-hTERT Ab H231 specific for hTERT peptide 900-1130.

View larger version (46K): [in this window] [in a new window]   FIGURE 2. hTERT protein is present in human thymocytes and peripheral blood T lymphocytes independent of their expression of telomerase activity. A, Western blot images of hTERT protein levels in thymocyte subsets and peripheral CD4+ and CD8+ T cells are shown. B, Western blot images of hTERT protein level in human peripheral blood CD4+ T cells and fibroblasts. The blot was also probed with anti-tubulin Ab (as a loading control). C, The relative abundance of hTERT protein levels in thymocytes and blood T cells is shown. The hTERT level shown in A was quantified by densitometer and ImageQuant software (Molecular Dynamics, Sunnyvale, CA), and relative hTERT level was normalized on the basis of cell-equivalents. D, Telomerase activity was measured from the same cells by the TRAP assay normalized by cell equivalents. The internal control (IC) is indicated at the right.

Telomerase induction does not require increase of hTERT protein in activated CD4⁺ T cells

Stimulation of peripheral blood T cells through the TCR/CD3 complex alone or in combination with costimulatory receptor results in induction of telomerase activity (7, 17, 18). To determine whether hTERT protein is regulated in stimulated T cells, we treated freshly isolated peripheral blood naive and memory CD4⁺ T cells with anti-CD3 alone or anti-CD3 plus anti-CD28 (anti-CD3/CD28) mAbs. Anti-CD3 stimulation induced significant telomerase activity in both naive and memory CD4⁺ T cells in the absence of any detectable increase in hTERT protein and without detectable cellular proliferation (Fig. 3). In contrast, hTERT protein, telomerase activity, and cellular proliferation were all significantly increased in both naive and memory CD4⁺ T cells after anti-CD3/CD28 stimulation (Fig. 3). Therefore, induction of telomerase activity in CD4⁺ T cells does not require a net increase in hTERT protein.

View larger version (35K): [in this window] [in a new window]   FIGURE 3. Expression of hTERT protein, telomerase activity, and proliferation in naive (N) and memory (M) CD4+ T cells after in vitro stimulation. A, Expression of hTERT protein in naive and memory CD4+ T cells before and after stimulation with anti-CD3 alone or with anti-CD3 plus anti-CD28. B, The relative abundance of hTERT protein levels in resting and stimulated naive and memory CD4+ T cells is shown. The hTERT level shown in A was quantified by densitometer and ImageQuant software and was normalized on the basis of cell equivalents. Telomerase activity (C) and proliferation (D) of the same cells before and after stimulation. Telomerase was measured by the TRAP assay. Cellular proliferation was measured by the incorporation of [3H]thymidine in the presence or absence of stimulation.

It has been reported that constitutive phosphorylation of hTERT is found in a tumor cell line (29), but the regulation of hTERT phosphorylation has not previously been characterized in normal somatic cells. To determine whether phosphorylation of hTERT is regulated during T cell activation, we cultured freshly isolated peripheral blood CD4⁺ T cells with anti-CD3 alone, with anti-CD3/CD28, or with IL-2 for 1.5 days and pulsed with [³²P]orthophosphate for 4 h. Subsequent immunoprecipitation with anti-hTERT Ab revealed phosphorylation of hTERT in CD4⁺ T cells cultured with either anti-CD3 alone or anti-CD3/CD28 but not in cells cultured with IL-2 alone (Fig. 4A), indicating that phosphorylation of hTERT is a regulated event after T cell activation. hTERT in the tumor cell line 293 was constitutively phosphorylated (Fig. 4A). The intensity of ³²P-labeled hTERT relative to total hTERT detected by immunoprecipitation-Western blot was 3-fold higher in CD4⁺ T cells stimulated by anti-CD3/CD28 (relative signal intensity = 1.48 ± 0.47) than in cells stimulated by anti-CD3 alone (relative signal intensity = 0.50 ± 0.16) (Fig. 4B). No detectable phosphorylation was observed in control cells cultured with IL-2 (relative signal intensity = 0.02 ± 0.03).

View larger version (48K): [in this window] [in a new window]   FIGURE 4. Phosphorylation of hTERT during telomerase activation in CD4+ T cells. A, hTERT phosphorylated in activated CD4+ T cells. The experiment shown is representative of three independent experiments. Tumor cell line 293 was used as control. Immunoprecipitates of cell lysates with anti-hTERT Ab (+) or normal rabbit serum (–) were separated by 12% SDS-PAGE. Displayed are autoradiograph images (upper panel). The location of phosphorylated hTERT was confirmed by Western blot (lower panel). The location of hTERT is indicated at the right. B, Quantitation of phosphorylated hTERT in culture CD4+ T cells. The relative intensity of phosphorylated hTERT was calculated as the intensity of [32P]hTERT signal normalized to total hTERT as determined by Western blot. The quantitation represents means and SDs of results from three independent experiments.

The physiological role of telomerase in synthesis of telomeric repeats occurs in the cell nucleus. However, it is unknown whether the cellular distribution of telomerase components is regulated during cell activation or differentiation in normal somatic cells. To address the subcellular localization of hTERT protein and to determine whether telomerase activation is accompanied by changes in hTERT localization, we stained freshly isolated or activated CD4⁺ T cells with anti-hTERT Ab and analyzed cellular localization of hTERT by immunofluorescence confocal microscopy. Interestingly, we observed a dramatic change in distribution of hTERT protein in CD4⁺ T cells after activation (Fig. 5A). In nonactivated freshly isolated CD4⁺ T cells, hTERT protein was found only in the cytoplasm and not detectably in the nucleus. In contrast, hTERT was present in the nucleus and cytoplasm of activated T cells. The translocation of hTERT protein to the nucleus was observed in anti-CD3-stimulated T cells in the absence of a net increase of total cellular hTERT. Consistent with Western blot results, total hTERT protein was most abundant in T cells after stimulation with anti-CD3/CD28.

View larger version (44K): [in this window] [in a new window]   FIGURE 5. Translocation of hTERT protein from cytoplasm to nucleus after in vitro activation. A, Confocal images of peripheral blood CD4+ T cells freshly isolated, or after 3 days in vitro stimulation with anti-CD3 Ab or anti-CD3/CD28 Abs. hTERT protein was in the cytosol of freshly isolated resting CD4+ T cells and was translocated into the nucleus after activation. DNA counterstaining (4',6'-diamidino-2-phenylindole (DAPI), blue) of the same cells is shown in the bottom panel. B, Western blot images (upper panel) and telomerase activity (lower panel) of cytoplasm (c) and nuclear (n) fractions of resting and activated CD4+ T cells, representative of three independent donors.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
Previous reports have described mechanisms of telomerase regulation by control of hTERT transcription (13, 30, 31), alternative splicing of hTERT (14, 16), and assembly of telomerase holoenzyme (32). Recently, it has been demonstrated that telomerase activity can be induced in multiple cell types (30, 33), including human CD8⁺ T cells, through transfection of hTERT (33, 34). The findings presented here are consistent with previous studies in that stimulation of CD4 T cells with anti-CD3/CD28 does result in increased levels of hTERT protein in association with increased telomerase activity. However, in the present report, we describe evidence that human T lymphocytes also regulate telomerase activity by novel mechanisms distinct from those previously described. First, we demonstrate that telomerase activity in CD4⁺ T cells is regulated by mechanisms other than the expression of hTERT protein. This is supported by the finding that hTERT protein is present in both immature (thymocytes) and mature (peripheral blood) T cells regardless of their telomerase activity status, and by the demonstration that induction of telomerase activity in CD4⁺ T cells after in vitro stimulation does not require an increase of hTERT protein. Second, we observe that T cell activation results in hTERT phosphorylation coincident with telomerase activation. Third, we present evidence that hTERT nuclear translocation is a regulated process in response to CD4⁺ T cell activation.

The mechanism underlying regulation of telomerase activity in human T lymphocytes during development and activation appears different from that previously described in other normal somatic cells and tumor cells. The reported mechanisms of regulating telomerase in other normal somatic cells are transcriptional repression and alternative splicing of hTERT. In contrast, tumor cells that constitutively express high levels of telomerase activity express hTERT protein in phosphorylated form (29, 35) that is located predominantly in the nucleus (25, 36, 37). Our results indicate that the presence of hTERT protein in resting T cells is not sufficient to determine telomerase activity. Indeed, we have identified two regulated events that are associated with telomerase activation in CD4⁺ T lymphocytes independent of total levels of hTERT protein: phosphorylation and nuclear translocation of hTERT. Although the precise role of hTERT phosphorylation in regulation of telomerase activity remains to be elucidated, it is conceivable that nuclear translocation of telomerase from a presumably nonfunctional cytosolic location to a physiologically relevant nuclear compartment, where its activity can mediate functions such as telomere elongation, is an important regulatory process for telomerase function in CD4⁺ T cells.

Regulation of telomerase activity in human lymphocytes appears to be a complex process. Determination of how the signals resulting from engagement of TCR/CD3 and costimulatory receptors on the surface of T cells lead to the phosphorylation and nuclear translocation of hTERT, and ultimately lead to telomerase activation will require further studies. Lymphocytes, normal somatic cells that express telomerase in a highly regulated manner, provide a valuable model system in which to study the physiological regulation and functions of telomerase in human cells. Information gained from the study of telomerase regulation and function in lymphocytes will not only enhance our understanding of lymphocyte replication but is also likely to have broad applications for somatic cell biology.

	Acknowledgments

 
We thank Drs. Stephen Shaw (National Cancer Institute) and Carl June and Bruce Levine (University of Pennsylvania) for providing valuable Abs, Drs. Magda Juhaszova and Steven Sollott (National Institute on Aging) for help in confocal microscopy, and Fairfax County Hospital and National Institutes of Health Blood Bank for assistance in obtaining thymus and blood. We thank Drs. David Schlessinger and Nikki Holbrook for comments on the manuscript.

	Footnotes

 
¹ Address correspondence and reprint request to Dr. Nan-ping Weng, Laboratory of Immunology, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Box 21, Baltimore, MD 21224.

² Abbreviations used in this paper: hTER, telomerase RNA template; hTERT, telomerase reverse transcriptase; TRAP, telomeric repeats amplification protocol.

Received for publication November 9, 2000. Accepted for publication February 26, 2001.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Blackburn, E. H.. 2000. Telomere states and cell fates. Nature 408:53.[Medline]
2. Harley, C. B., S. W. Sherwood. 1997. Telomerase, checkpoints and cancer. Cancer Surv. 29:263.[Medline]
3. Greider, C. W.. 1998. Telomerase activity, cell proliferation, and cancer. Proc. Natl. Acad. Sci. USA 95:90.[Free Full Text]
4. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich, J. W. Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011.[Abstract/Free Full Text]
5. Wright, W. E., M. A. Piatyszek, W. E. Rainey, W. Byrd, J. W. Shay. 1996. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18:173.[Medline]
6. Broccoli, D., J. W. Young, T. de Lange. 1995. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92:9082.[Abstract/Free Full Text]
7. Hiyama, K., Y. Hirai, S. Kyoizumi, M. Akiyama, E. Hiyama, M. A. Piatyszek, J. W. Shay, S. Ishioka, M. Yamakido. 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:3711.[Abstract]
8. Weng, N. P., K. S. Hathcock, R. J. Hodes. 1998. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 9:151.[Medline]
9. Morrison, S. J., K. R. Prowse, P. Ho, I. L. Weissman. 1996. Telomerase activity in hematopoietic cells is associated with self- renewal potential. Immunity 5:207.[Medline]
10. Chiu, C. P., W. Dragowska, N. W. Kim, H. Vaziri, J. Yui, T. E. Thomas, C. B. Harley, P. M. Lansdorp. 1996. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14:239.[Abstract]
11. Feng, J., W. D. Funk, S. S. Wang, S. L. Weinrich, A. A. Avilion, C. P. Chiu, R. R. Adams, E. Chang, R. C. Allsopp, J. Yu. 1995. The RNA component of human telomerase. Science 269:1236.[Abstract/Free Full Text]
12. Nakamura, T. M., G. B. Morin, K. B. Chapman, S. L. Weinrich, W. H. Andrews, J. Lingner, C. B. Harley, T. R. Cech. 1997. Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955.[Abstract/Free Full Text]
13. Meyerson, M., C. M. Counter, E. N. Eaton, L. W. Ellisen, P. Steiner, S. D. Caddle, L. Ziaugra, R. L. Beijersbergen, M. J. Davidoff, Q. Liu, S. Bacchetti, D. A. Haber, R. A. Weinberg. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785.[Medline]
14. Ulaner, G. A., J. F. Hu, T. H. Vu, L. C. Giudice, A. R. Hoffman. 1998. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:4168.[Abstract/Free Full Text]
15. Kilian, A., D. D. Bowtell, H. E. Abud, G. R. Hime, D. J. Venter, P. K. Keese, E. L. Duncan, R. R. Reddel, R. A. Jefferson. 1997. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6:2011.[Abstract/Free Full Text]
16. Ulaner, G. A., J. F. Hu, T. H. Vu, H. Oruganti, L. C. Giudice, A. R. Hoffman. 2000. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int. J. Cancer 85:330.[Medline]
17. Buchkovich, K. J., C. W. Greider. 1996. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol. Biol. Cell 7:1443.[Abstract]
18. Weng, N., B. L. Levine, C. H. June, R. J. Hodes. 1996. Regurated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183:2471.[Abstract/Free Full Text]
19. Bodnar, A. G., N. W. Kim, R. B. Effros, C. P. Chiu. 1996. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228:58.[Medline]
20. Weng, N. P., L. Granger, R. J. Hodes. 1997. Telomere lengthening and telomerase activation during human B cell differentiation. Proc. Natl. Acad. Sci. USA 94:10827.[Abstract/Free Full Text]
21. Liu, K., M. M. Schoonmaker, B. L. Levine, C. H. June, R. J. Hodes, N. Weng. 1999. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. USA 96:5147.[Abstract/Free Full Text]
22. Levine, B. L., W. B. Bernstein, M. Connors, N. Craighead, T. Lindsten, C. B. Thompson, C. H. June. 1997. Effects of CD28 costimulation on long-term proliferation of CD4⁺ T cells in the absence of exogenous feeder cells. J. Immunol. 159:5921.[Abstract]
23. Weng, N. P., B. L. Levine, C. H. June, R. J. Hodes. 1995. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. USA 92:11091.[Abstract/Free Full Text]
24. Latinis, K. M., L. A. Norian, S. L. Eliason, G. A. Koretzky. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:31427.[Abstract/Free Full Text]
25. Martin-Rivera, L., E. Herrera, J. P. Albar, M. A. Blasco. 1998. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl. Acad. Sci. USA 95:10471.[Abstract/Free Full Text]
26. Ning, Y., M. Lovell, L. Taylor, O. M. Pereira-Smith. 1992. Isolation of monochromosomal hybrids following fusion of human diploid fibroblast-derived microcells with mouse A9 cells. Cytogenet. Cell Genet. 60:79.[Medline]
27. Kim, N. W., F. Wu. 1997. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25:2595.[Abstract/Free Full Text]
28. Harlow, E., D. Lane. 1999. Immunoprecipitation. E. Harlow, and D. Lane, eds. Using Antibodies: A Laboratory Manual 256. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
29. Li, H., L. Zhao, Z. Yang, J. W. Funder, J. P. Liu. 1998. Telomerase is controlled by protein kinase C in human breast cancer cells. J. Biol. Chem. 273:33436.[Abstract/Free Full Text]
30. Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C. P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner, W. E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349.[Abstract/Free Full Text]
31. Horikawa, I., P. L. Cable, C. Afshari, J. C. Barrett. 1999. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59:826.[Abstract/Free Full Text]
32. Holt, S. E., D. L. Aisner, J. Baur, V. M. Tesmer, M. Dy, M. Ouellette, J. B. Trager, G. B. Morin, D. O. Toft, J. W. Shay, W. E. Wright, M. A. White. 1999. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev. 13:817.[Abstract/Free Full Text]
33. Migliaccio, M., M. Amacker, T. Just, P. Reichenbach, D. Valmori, J. C. Cerottini, P. Romero, M. Nabholz. 2000. Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8⁺ T lymphocyte immortalization. J. Immunol. 165:4978.[Abstract/Free Full Text]
34. Hooijberg, E., J. J. Ruizendaal, P. J. Snijders, E. W. Kueter, J. M. Walboomers, H. Spits. 2000. Immortalization of human CD8⁺ T cell clones by ectopic expression of telomerase reverse transcriptase. J. Immunol. 165:4239.[Abstract/Free Full Text]
35. Kang, S. S., T. Kwon, D. Y. Kwon, S. I. Do. 1999. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 274:13085.[Abstract/Free Full Text]
36. Harrington, L., W. Zhou, T. McPhail, R. Oulton, D. S. Yeung, V. Mar, M. B. Bass, M. O. Robinson. 1997. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 11:3109.[Abstract/Free Full Text]
37. Seimiya, H., H. Sawada, Y. Muramatsu, M. Shimizu, K. Ohko, K. Yamane, T. Tsuruo. 2000. Involvement of 14–3-3 proteins in nuclear localization of telomerase. EMBO J. 19:2652.[Medline]

This article has been cited by other articles:

				B. Zhang, Y. X. Bai, H. H. Ma, F. Feng, R. Jin, Z. L. Wang, J. Lin, S. P. Sun, P. Yang, X. X. Wang, et al. Silencing PinX1 Compromises Telomere Length Maintenance As Well As Tumorigenicity in Telomerase-Positive Human Cancer Cells Cancer Res., January 1, 2009; 69(1): 75 - 83. [Abstract] [Full Text] [PDF]

				M. ZAVLARIS, K. ANGELOPOULOU, I. VLEMMAS, and N. PAPAIOANNOU Telomerase Reverse Transcriptase (TERT) Expression in Canine Mammary Tissues: A Specific Marker for Malignancy? Anticancer Res, January 1, 2009; 29(1): 319 - 325. [Abstract] [Full Text] [PDF]

				S. Ahmed, J. F. Passos, M. J. Birket, T. Beckmann, S. Brings, H. Peters, M. A. Birch-Machin, T. von Zglinicki, and G. Saretzki Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress J. Cell Sci., April 1, 2008; 121(7): 1046 - 1053. [Abstract] [Full Text] [PDF]

				Y. Yang, J. An, and N.-p. Weng Telomerase Is Involved in IL-7-Mediated Differential Survival of Naive and Memory CD4+ T Cells J. Immunol., March 15, 2008; 180(6): 3775 - 3781. [Abstract] [Full Text] [PDF]

				F. J. Plunkett, O. Franzese, H. M. Finney, J. M. Fletcher, L. L. Belaramani, M. Salmon, I. Dokal, D. Webster, A. D. G. Lawson, and A. N. Akbar The Loss of Telomerase Activity in Highly Differentiated CD8+CD28-CD27- T Cells Is Associated with Decreased Akt (Ser473) Phosphorylation J. Immunol., June 15, 2007; 178(12): 7710 - 7719. [Abstract] [Full Text] [PDF]

				A. N. Akbar and M. Vukmanovic-Stejic Telomerase in T Lymphocytes: Use It and Lose It? J. Immunol., June 1, 2007; 178(11): 6689 - 6694. [Abstract] [Full Text] [PDF]

				P.-H. Wang, G.-D. Chen, H. Chang, S.-F. Yang, C.-P. Han, L.-Y. Lin, and J.-L. Ko High Expression of Human Telomerase Reverse Transcriptase in High-Grade Intraepithelial Neoplasia and Carcinoma of Uterine Cervix and Its Correlation With Human Papillomavirus Infection Reproductive Sciences, May 1, 2007; 14(4): 338 - 348. [Abstract] [PDF]

				B. S. Emerald, Y. Chen, T. Zhu, Z. Zhu, K.-O. Lee, P. D. Gluckman, and P. E. Lobie {alpha}CP1 Mediates Stabilization of hTERT mRNA by Autocrine Human Growth Hormone J. Biol. Chem., January 5, 2007; 282(1): 680 - 690. [Abstract] [Full Text] [PDF]

				M. Coussens, Y. Yamazaki, S. Moisyadi, R. Suganuma, R. Yanagimachi, and R. Allsopp Regulation and Effects of Modulation of Telomerase Reverse Transcriptase Expression in Primordial Germ Cells During Development Biol Reprod, November 1, 2006; 75(5): 785 - 791. [Abstract] [Full Text] [PDF]

				Y.-L. Wu, C. Dudognon, E. Nguyen, J. Hillion, F. Pendino, I. Tarkanyi, J. Aradi, M. Lanotte, J.-H. Tong, G.-Q. Chen, et al. Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths J. Cell Sci., July 1, 2006; 119(13): 2797 - 2806. [Abstract] [Full Text] [PDF]

				O. Adotevi, K. Mollier, C. Neuveut, S. Cardinaud, E. Boulanger, B. Mignen, W.-H. Fridman, M. Zanetti, P. Charneau, E. Tartour, et al. Immunogenic HLA-B*0702-Restricted Epitopes Derived from Human Telomerase Reverse Transcriptase That Elicit Antitumor Cytotoxic T-Cell Responses. Clin. Cancer Res., May 15, 2006; 12(10): 3158 - 3167. [Abstract] [Full Text] [PDF]

				D. Ogawa, T. Nomiyama, T. Nakamachi, E. B. Heywood, J. F. Stone, J. P. Berger, R. E. Law, and D. Bruemmer Activation of Peroxisome Proliferator-Activated Receptor {gamma} Suppresses Telomerase Activity in Vascular Smooth Muscle Cells Circ. Res., April 14, 2006; 98(7): e50 - e59. [Abstract] [Full Text] [PDF]

				V. Russo, P. Berardinelli, A. Martelli, O. Di Giacinto, D. Nardinocchi, D. Fantasia, and B. Barboni Expression of Telomerase Reverse Transcriptase Subunit (TERT) and Telomere Sizing in Pig Ovarian Follicles J. Histochem. Cytochem., April 1, 2006; 54(4): 443 - 455. [Abstract] [Full Text] [PDF]

				S. Jagadeesh, S. Kyo, and P. P. Banerjee Genistein Represses Telomerase Activity via Both Transcriptional and Posttranslational Mechanisms in Human Prostate Cancer Cells Cancer Res., February 15, 2006; 66(4): 2107 - 2115. [Abstract] [Full Text] [PDF]

				R. Hrdlickova, J. Nehyba, A. S. Liss, and H. R. Bose Jr. Mechanism of Telomerase Activation by v-Rel and Its Contribution to Transformation J. Virol., January 1, 2006; 80(1): 281 - 295. [Abstract] [Full Text] [PDF]

				M. Quante, S. Heeg, A. von Werder, G. Goessel, C. Fulda, M. Doebele, H. Nakagawa, R. Beijersbergen, H. E. Blum, and O. G. Opitz Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis Carcinogenesis, November 1, 2005; 26(11): 1879 - 1889. [Abstract] [Full Text] [PDF]

				S Bravaccini, M A Sanchini, A Amadori, L Medri, L Saragoni, D Calistri, F Monti, A Volpi, and D Amadori Potential of telomerase expression and activity in cervical specimens as a diagnostic tool J. Clin. Pathol., September 1, 2005; 58(9): 911 - 914. [Abstract] [Full Text] [PDF]

				J. P. Gardner, S. Li, S. R. Srinivasan, W. Chen, M. Kimura, X. Lu, G. S. Berenson, and A. Aviv Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition Circulation, May 3, 2005; 111(17): 2171 - 2177. [Abstract] [Full Text] [PDF]

				K. Kawauchi, K. Ihjima, and O. Yamada IL-2 Increases Human Telomerase Reverse Transcriptase Activity Transcriptionally and Posttranslationally through Phosphatidylinositol 3'-Kinase/Akt, Heat Shock Protein 90, and Mammalian Target of Rapamycin in Transformed NK Cells J. Immunol., May 1, 2005; 174(9): 5261 - 5269. [Abstract] [Full Text] [PDF]

				S. Lantuejoul, J. C. Soria, L. Morat, P. Lorimier, D. Moro-Sibilot, L. Sabatier, C. Brambilla, and E. Brambilla Telomere Shortening and Telomerase Reverse Transcriptase Expression in Preinvasive Bronchial Lesions Clin. Cancer Res., March 1, 2005; 11(5): 2074 - 2082. [Abstract] [Full Text] [PDF]

				J. M. Ritz, O. Kuhle, S. Riethdorf, B. Sipos, W. Deppert, C. Englert, and C. Gunes A Novel Transgenic Mouse Model Reveals Humanlike Regulation of an 8-kbp Human TERT Gene Promoter Fragment in Normal and Tumor Tissues Cancer Res., February 15, 2005; 65(4): 1187 - 1196. [Abstract] [Full Text] [PDF]

				T. Nikitina and C. L. Woodcock Closed chromatin loops at the ends of chromosomes J. Cell Biol., July 19, 2004; 166(2): 161 - 165. [Abstract] [Full Text] [PDF]

				L. Gammaitoni, K. C. Weisel, M. Gunetti, K.-D. Wu, S. Bruno, S. Pinelli, A. Bonati, M. Aglietta, M. A. S. Moore, and W. Piacibello Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication Blood, June 15, 2004; 103(12): 4440 - 4448. [Abstract] [Full Text] [PDF]

				J. Haendeler, J. Hoffmann, J. F. Diehl, M. Vasa, I. Spyridopoulos, A. M. Zeiher, and S. Dimmeler Antioxidants Inhibit Nuclear Export of Telomerase Reverse Transcriptase and Delay Replicative Senescence of Endothelial Cells Circ. Res., April 2, 2004; 94(6): 768 - 775. [Abstract] [Full Text] [PDF]

				J. Lin and E. H. Blackburn Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA Genes & Dev., February 15, 2004; 18(4): 387 - 396. [Abstract] [Full Text] [PDF]

				J. Grimm, J M. Perez, L. Josephson, and R. Weissleder Novel Nanosensors for Rapid Analysis of Telomerase Activity Cancer Res., January 15, 2004; 64(2): 639 - 643. [Abstract] [Full Text] [PDF]

				S. Kyo, K. Masutomi, Y. Maida, T. Kanaya, N. Yatabe, M. Nakamura, M. Tanaka, M. Takarada, I. Sugawara, S. Murakami, et al. Significance of Immunological Detection of Human Telomerase Reverse Transcriptase: Re-Evaluation of Expression and Localization of Human Telomerase Reverse Transcriptase Am. J. Pathol., September 1, 2003; 163(3): 859 - 867. [Abstract] [Full Text] [PDF]

				A. Roth, H. Yssel, J. Pene, E. A. Chavez, M. Schertzer, P. M. Lansdorp, H. Spits, and R. M. Luiten Telomerase levels control the lifespan of human T lymphocytes Blood, August 1, 2003; 102(3): 849 - 857. [Abstract] [Full Text] [PDF]

				J. Haendeler, J. Hoffmann, R. P. Brandes, A. M. Zeiher, and S. Dimmeler Hydrogen Peroxide Triggers Nuclear Export of Telomerase Reverse Transcriptase via Src Kinase Family-Dependent Phosphorylation of Tyrosine 707 Mol. Cell. Biol., July 1, 2003; 23(13): 4598 - 4610. [Abstract] [Full Text] [PDF]

				K.-D. Wu, L. M. Orme, J. Shaughnessy Jr, J. Jacobson, B. Barlogie, and M. A. S. Moore Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival Blood, June 15, 2003; 101(12): 4982 - 4989. [Abstract] [Full Text] [PDF]

				W. C. Hahn Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer J. Clin. Oncol., May 15, 2003; 21(10): 2034 - 2043. [Abstract] [Full Text] [PDF]

				V. Gorbunova, A. Seluanov, and O. M. Pereira-Smith Evidence That High Telomerase Activity May Induce a Senescent-like Growth Arrest in Human Fibroblasts J. Biol. Chem., February 21, 2003; 278(9): 7692 - 7698. [Abstract] [Full Text] [PDF]

				M. Akiyama, T. Hideshima, T. Hayashi, Y.-T. Tai, C. S. Mitsiades, N. Mitsiades, D. Chauhan, P. Richardson, N. C. Munshi, and K. C. Anderson Nuclear Factor-{kappa}B p65 Mediates Tumor Necrosis Factor {alpha}-induced Nuclear Translocation of Telomerase Reverse Transcriptase Protein Cancer Res., January 1, 2003; 63(1): 18 - 21. [Abstract] [Full Text] [PDF]

				R. C. Allsopp, S. Cheshier, and I. L. Weissman Telomerase Activation and Rejuvenation of Telomere Length in Stimulated T Cells Derived from Serially Transplanted Hematopoietic Stem Cells J. Exp. Med., December 2, 2002; 196(11): 1427 - 1433. [Abstract] [Full Text] [PDF]

				J. Hernandez, F. Garcia-Pons, Y. C. Lone, H. Firat, J. D. Schmidt, P. Langlade-Demoyen, and M. Zanetti Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells PNAS, September 17, 2002; 99(19): 12275 - 12280. [Abstract] [Full Text] [PDF]

				Y.-S. Cong, W. E. Wright, and J. W. Shay Human Telomerase and Its Regulation Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 407 - 425. [Abstract] [Full Text] [PDF]

				M. Akiyama, T. Hideshima, T. Hayashi, Y.-T. Tai, C. S. Mitsiades, N. Mitsiades, D. Chauhan, P. Richardson, N. C. Munshi, and K. C. Anderson Cytokines Modulate Telomerase Activity in a Human Multiple Myeloma Cell Line Cancer Res., July 1, 2002; 62(13): 3876 - 3882. [Abstract] [Full Text] [PDF]

				K. Liu, M. Catalfamo, Y. Li, P. A. Henkart, and N.-p. Weng IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells PNAS, April 30, 2002; 99(9): 6192 - 6197. [Abstract] [Full Text] [PDF]

				J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson Natural and pharmacological regulation of telomerase Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865. [Abstract] [Full Text] [PDF]

				B. N. Armbruster, S. S. R. Banik, C. Guo, A. C. Smith, and C. M. Counter N-Terminal Domains of the Human Telomerase Catalytic Subunit Required for Enzyme Activity in Vivo Mol. Cell. Biol., November 15, 2001; 21(22): 7775 - 7786. [Abstract] [Full Text] [PDF]

				W. C. Hahn Telomerase and Cancer: Where and When? Clin. Cancer Res., October 1, 2001; 7(10): 2953 - 2954. [Full Text] [PDF]

				K. S. J. Elenitoba-Johnson Complex Regulation of Telomerase Activity : Implications for Cancer Therapy Am. J. Pathol., August 1, 2001; 159(2): 405 - 410. [Full Text]

				K. Liu, M. Catalfamo, Y. Li, P. A. Henkart, and N.-p. Weng IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells PNAS, April 30, 2002; 99(9): 6192 - 6197. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, K. Articles by Weng, N.-p. Search for Related Content PubMed PubMed Citation Articles by Liu, K. Articles by Weng, N.-p.